6533b872fe1ef96bd12d3e29

RESEARCH PRODUCT

Ultra-long-acting insulin degludec has consistently lower pharmacodynamic variability than insulin glargine over 24 h at steady state

Silvio BuscemiT HeiseL HermanskiL NosekA FeldmannS RasmussenP NicozianiS. Haahr

subject

diabetes insulin degludec pharmacodynamic variability
yearjournalcountryeditionlanguage
2012-01-01
10.1007/s11739-012-0882-xhttp://hdl.handle.net/10447/79630